Hani Keshavarz Alikhani

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 4

Top Topics

Circulating Tumor

Top Venues

Bioengineering (Basel, Switzerland)

This page only lists publications with an associated author ORCID identifier.

Publications

Samieh Asadian, Abbas Piryaei, Nematollah Gheibi, Bagher Aziz Kalantari, Mohamad Reza Davarpanah, Mehdi Azad, Valentina Kapustina, Mehdi Alikhani, Sahar Moghbeli Nejad, Hani Keshavarz Alikhani, Morteza Mohamadi, Anastasiia I Shpichka, Vladimir I Yusupov, Moustapha Hassan, Abdolhossein Shahverdi
Correction: Asadian et al. Rhenium Perrhenate ( 188 ReO4) Induced Apoptosis and Reduced Cancerous Phenotype in Liver Cancer Cells. Cells 2022, 11 , 305. Cells 13 (17) (2024)
Mahsa Salehi, Zohre Miri Lavasani, Hani Keshavarz Alikhani, Bahare Shokouhian, Moustapha Hassan, Mustapha Najimi, Abdolhossein Shahverdi
Circulating Tumor Cells as a Promising Tool for Early Detection of Hepatocellular Carcinoma. Cells 12 (18) (2023)
Samieh Asadian, Abbas Piryaei, Nematollah Gheibi, Bagher Aziz Kalantari, Mohamad Reza Davarpanah, Mehdi Azad, Valentina Kapustina, Mehdi Alikhani, Sahar Moghbeli Nejad, Hani Keshavarz Alikhani, Morteza Mohamadi, Anastasiia I Shpichka, Vladimir I Yusupov, Moustapha Hassan, Abdolhossein Shahverdi
Rhenium Perrhenate ( 188 ReO 4 ) Induced Apoptosis and Reduced Cancerous Phenotype in Liver Cancer Cells. Cells 11 (2) (2022)
Mahsa Ghasemzad, Mahdieh Hashemi, Zohre Miri Lavasani, Nikoo Hossein-Khannazer, Haleh Bakhshandeh, Roberto Gramignoli, Hani Keshavarz Alikhani, Mustapha Najimi, Saman Nikeghbalian, Abdolhossein Shahverdi
Novel Gene-Correction-Based Therapeutic Modalities for Monogenic Liver Disorders. Bioengineering (Basel, Switzerland) 9 (8) (2022)